Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SRV Group Plc: Managers' transactions – Olli-Pekka Kallasvuo

SRV GROUP PLC       MANAGERS' TRANSACTIONS   2 JUNE 2020     9.30 EET SRV Group Plc: Managers' transactions – Olli-Pekka Kallasvuo Notification under the EU Market Abuse Regulation, article 19 SRV Yhtiöt Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Kallasvuo, Olli-Pekka Position: Member of the Board/Deputy member Issuer: SRV Yhtiöt Oyj LEI: 743700GB29FXC0VXF414 Notification type: INITIAL NOTIFICATION Reference number: 743700GB29FXC0VXF414_20200601125502_4 ____________________

Nordic winners ready for EY World Entrepreneur Of The Year 2020

This year, the world’s largest program of its kind; EY World Entrepreneur Of The Year  is going virtual. On 4 June, finalists from 31 countries will compete online - and ultimately one winner will become EY World Entrepreneur Of The Year 2020. The international finals are the culmination of regional events in 150 cities around the world.“More than ever given these unprecedented times, it is important to learn from and recognize the unstoppable entrepreneurs who have a significant impact on the economy, on job creation, on innovation and on their communities and

Dividend amount in XACT Sverige (UCITS ETF)

The dividend amount of the above stated Exchange Traded Fund is SEK 19.90 per fund unit. Registered holder of fund units on the record day will receive dividend.   The schedule for the dividend is as follows: June 8         Last day to trade fund units including the right to receive dividendJune 9         Ex-dividend; the fund units are traded ex dividendJune 10       Record dayJune 15       Payment day For further information, please contact: Magdalena Wahlqvist Alveskog, CEO Handelsbanken Fonder AB:  +46 (0)8 701 15 55 This information is of the type that

Nordic Nanovector to Present at Upcoming Jefferies Virtual Healthcare Conference and ABG Sundal Collier Virtual Oncology Seminar

Oslo, Norway, 2 June 2020 Nordic Nanovector ASA (OSE: NANO) announces that members of its management team will present at Jefferies Virtual Healthcare Conference, taking place 2-4 June 2020. Nordic Nanovector will also present at ABG Sundal Collier Virtual Oncology Seminar 10 June 2020. Presentations details are as follows: Jefferies Virtual Healthcare ConferenceDate: Tuesday, 2 June 2020Time: 16:30 CET ABG Sundal Collier Virtual Oncology SeminarDate: Wednesday, 10 June 2020Time: 10:25 CET The company presentation will be available on Nordic Nanovector’s Investors

NCC to construct section of Tvärbanan light rail line

NCC has been commissioned by Stockholm Public Transport (SL) and the City of Sundbyberg to carry out preparatory work for the Tvärbanan light rail line by the new Rissne station in the north of Stockholm. The order value is approximately SEK 265 million. Image: NCCThe Tvärbanan’s Kista line will run between Ulvsunda and Helenelund and will include ten new stations across three municipalities: Stockholm, Sundbyberg and Sollentuna. Next to the Rissne station, NCC has been commissioned to perform preparatory works featuring technically complex elements. NCC will carry out

Read original

Zwipe appoints new Executive Vice President Strategy & Channels

OSLO, NORWAY– 02 June 2020 – Zwipe AS announces that Bishwajit Choudhary has accepted the position of Executive Vice President Strategy & Channels at Zwipe, commencing 2 June 2020.  He will lead Zwipe’s engagement efforts towards banks, global and domestic card schemes, selected retailers and other important payments ecosystem stakeholders. Based in Oslo, Mr. Choudhary brings two decades of experience from Nets where he led many new business initiatives within Digital-ID, electronic signatures and mobile authentication for international clients. As the Group SVP (Strategy) he led Nets'

SKF factories to be carbon neutral by 2030

Gothenburg, 2 June 2020: Since 2015, SKF has decreased its manufacturing carbon footprint by 36% and is already operating two carbon neutral factories. Today, SKF announces its aim to achieve a fully carbon neutral manufacturing footprint by 2030. The 2030 target will cover SKF’s own manufacturing operations, i.e. SKF’s scope 1 and 2 emissions. It will be achieved by a combination of process improvements, energy efficient machinery, and procurement and generation of renewable energy. As a last resort, SKF may also purchase high quality carbon offsets. Alrik Danielson, President and

Systemair's Interim Report for the fourth quarter will be presented on June 9

Press Release, 2 June 2020 Systemair ABs (NASDAQ OMX Stockholm: SYSR) Interim Report Q4 for the financial year 2019/20 will be published at 08:00 CET on June 9, 2020. A telephone conference will be held at 09:00 CET on June 9, 2020. The report will be presented by Roland Kasper, CEO, and Anders Ulff, CFO. In order to participate in the telephone conference:Call +46 8 566 426 51 alternative 0200 883 685 and enter code 95682375# minutes before start. The presentation will be published on group.systemair.com For further information contact:Roland Kasper, CEO, + 46 73 094 40

Miss Group announced winners of the Northern Tech Awards 2020 as the Fastest Growing Tech Company

Miss Group was announced as the fastest growing tech company at the Northern Tech Awards 2020 on 27th May. Presented by GP Bullhound, this virtual event was attended by hundreds of entrepreneurs, investors and business leaders from the global tech community.Mattias Kaneteg, founder and CEO of Miss Group, accepted the award from Edie Lush, an international technology journalist and author, who highlighted the + 200% revenue growth reported by Miss Group between 2017 and 2019. The audience heard that this had been achieved through both organic growth and acquisitions, and with financing

SynAct Pharma´s clinical trial application for AP1189 in Nephrotic Syndrome approved by the Danish Medical Agency

SynAct Pharma AB ("SynAct") today announced that the Danish Medical Agency has approved the company’s clinical trial application (CTA) for a Phase IIa study in idiopathic membranous nephropathy patients with Nephrotic Syndrome.In the Phase IIa study, AP1189 will be tested in a double-blind, placebo-controlled multicentre study as add-on therapy to ACE-inhibitor or Angiotensin-2 receptor antagonists in a once-daily dose regimen for four weeks with the primary purpose to show treatment effect on urinary protein excretion relative to pre-treatment levels and placebo. The patients will be dosed

Kallelse till årsstämma i Nilar International AB (publ) / Notice of annual general meeting in Nilar International AB (publ)

Aktieägarna i Nilar International AB, org. nr 556600-2977, ("Bolaget") kallas härmed till årsstämma tisdagen den 30 juni 2020 kl. 16.00 i Baker & McKenzie advokatbyrås lokaler på Vasagatan 7 i Stockholm. The shareholders of Nilar International AB, reg. no. 556600-2977, (the "Company"), are hereby convened to the annual general meeting to be held on Tuesday 30 June 2020, at 16.00 at Baker & McKenzie’s premises on Vasagatan 7 in Stockholm, Sweden.

Oncoinvent Announces Dosing of First Patient with Radspherin[® ]in Phase 1 Clinical Trial

Radiopharmaceutical company starts first-in-human trial in colorectal patients suffering from peritoneal carcinomatosisOncoinvent AS, a clinical stage radiopharmaceutical company developing novel radioisotope-based therapies to provide new therapeutic options for cancer patients, today announced that the first patient has been dosed in the phase 1, first-in-human clinical trial of it’s lead candidate compound Radspherin[®]. “Radspherin[®] represents a promising new approach for treating patients with metastates to the peritoneal cavity from colorectal cancer that may potentially provide

BERGENBIO CONFIRMS FIRST COVID19 PATIENT DOSED WITH BEMCENTINIB IN ACCORD TRIAL

Bergen, Norway – 02 June 2020: BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, today announces that dosing has commenced in the UK Government-backed Phase II clinical trial assessing bemcentinib in hospitalised COVID-19 patients. Bemcentinib was selected as the first candidate to be tested as part of the ACcelerating COVID-19 Research & Development platform (ACCORD) study, launched by the Department of Health and Social Care (DHSC) and UK Research and Innovation (UKRI) on 28[th] April

Seadrill Limited (SDRL) - First Quarter 2020 Results

Material impairments on assets and investments and a focus on restructuringHighlights ·Revenue down 19% at $321 million with lower proportion of reimbursable revenues ·Technical utilization of 95% and economic utilization of 93% ·Operating Loss of $1,284 million after making material asset impairments ·Adjusted EBITDA of $55 million, representing 17.1% margin ·Net loss attributable to shareholder of $1,564 million equivalent to net loss per share of $15.59 ·During the quarter we added $77 million in backlog, maintaining a total backlog figure of $2.

Sustainable production methods and traceability of materials for battery manufacturing

Press release 2.6.2020  The success of electric cars on the markets may be determined by production methods and origin information of battery materials in the future. VTT and Geological Survey of Finland GTK launched a three-year project with their industrial partners to promote the sustainable production methods and traceability of battery materials. A promising starting point for tracing the origin is offered by the fingerprint conserved in the metals, which may directly tell where the metals were mined.When examining transport emissions, electric cars using renewable electricity

Camurus announces submission of request for final approval of Brixadi™ for the treatment of opioid use disorder in the US

Lund, Sweden — 1 June 2020 — Camurus AB (NASDAQ STO: CAMX) today announces that the company’s US partner Braeburn has submitted a request for final approval of Brixadi™ (buprenorphine) weekly and monthly extended release injection for the treatment of opioid use disorder to the US Food and Drug Administration (FDA). On 21 December 2018, Brixadi (the US trade name for Buvidal[®]) was tentatively approved by the FDA, having met all regulatory requirements regarding efficacy, safety and quality. However, Brixadi was not eligible for marketing in the US because of an exclusivity period

SAGAX COMPLETES A DIRECTED ISSUE OF CLASS D COMMON SHARES, RAISING PROCEEDS OF SEK 513 MILLION

The board of directors in AB Sagax (publ) (”Sagax” or the ”Company”) has, based on the authorization granted by the annual general meeting on 6 May 2020, resolved on a directed issue of 18,000,000 class D common shares (the “Share issue”). Due to strong demand, the Share issue has been upsized with two million shares from what was previously communicated (refer to press release no.15). Through the Share issue, Sagax receives SEK 513m before transaction costs. The price of SEK 28,50 per share has been determined in an accelerated book building process and corresponds to a discount of 2,51

SDRL – Seadrill Limited Intention to Delist from the New York Stock Exchange (NYSE)

Hamilton, Bermuda, June 1, 2020 – Seadrill Limited ("Seadrill" or the "Company") today announces its intention to delist from the New York Stock Exchange (NYSE).  On March 26, 2020, Seadrill received written notice from the NYSE that it was not in compliance with the NYSE continued listing standard with respect to the minimum average share price required, because the average closing price of its common shares had fallen below $1.00 per share over a period of 30 consecutive trading days. On April 8, 2020, the Company provided the required notice to the NYSE, in which the Company stated

Keliber - EIA program of the Päiväneva mine and concentrator site submitted to the authorities

Keliber has submitted the program for environmental impact assessment (“EIA”) of the Päiväneva mine and concentrator site to the authorities. The program covers relevant environmental and social factors to be further investigated. The assessments will provide guidance for the industrial planning of the area. For further information please see Keliber’s press release today: https://www.keliber.fi/en/news/news-releases-and-publications/B8F144816971C87F/ Nordic Mining ASA holds an investment of 16.3% in Keliber.Oslo, 1 June 2020Nordic Mining ASANordic Mining ASA (www.nordicmining.

Subscription period postponed for the rights issue. Other conditions remain unchanged

SpectraCure AB (publ) postpones the subscription period for the rights issue which was announced on 5 May 2020. The new subscription period is between Friday, 5 June 2020 and Tuesday, 23 June 2020 inclusive. All other terms and conditions of the rights issue remain unchanged. The Board of Directors of SpectraCure AB (publ) has resolved to postpone the subscription period for the rights issue which was announced on 5 May 2020. The new subscription period is between Friday, 5 June 2020 and Tuesday, 23 June 2020 inclusive. The reason for this decision is that the registration of the

Sandvik completes the acquisition of QCT’s division for cutting tools

Sandvik has completed the previously announced acquisition of the cutting tools division of QUIMMCO CENTRO TECNOLÓGICO (QCT), a privately owned Mexican company offering integral machining solutions. In 2019, QCT’s cutting tools division generated revenues of about 90 million SEK with 130 employees. The deal has a limited impact on earnings per share from the start. QCT’s cutting tool division will be part of Seco Tools, a division within Sandvik Machining Solutions.   Stockholm, 1 June 2020  Sandvik AB For further information, contact Anna Vilogorac, Investor Relations,

The Nomination Committee's proposal for the Board of Directors and adjusted proposal for the Annual General Meeting 2020

In the notice of the Annual General Meeting of Brighter AB (publ) published on May 13, 2020, the Nomination Committee announced that it would get back with a proposal for the election of Board members. The Nomination Committee's proposal is presented below. The shareholder Recall Capital Nordic AB has also requested an adjustment of the proposed incentive program for the Board of Directors, which is described in full on Brighter's website https://brighter.se/. The Nomination Committee's proposalsThe Nomination Committee proposes that Truls Sjöstedt, Jan Stålemark, Emanuel Lipschütz and

MHI Vestas Offshore Wind A/S has signed a conditional agreement for the delivery of turbines comprising 1,140 MW for an offshore project in the UK

Vestas Wind Systems A/S, Aarhus, 01 June 2020Company announcement No. 22/2020   MHI Vestas Offshore Wind A/S has signed a conditional agreement for the delivery of turbines comprising 1,140 MW for an offshore project in the UK   MHI Vestas Offshore Wind A/S has signed a conditional agreement for the Seagreen offshore project in the UK. If and when the project translates into a firm order, Vestas Wind Systems A/S will disclose a company announcement about this. The project is to be delivered by MHI Vestas Offshore Wind and will not enter into the order backlog of Vestas Wind

There are no items matching the current filter
There are no more items matching the current filter
Back to top